ILiAD Biotechnologies

ILiAD Biotechnologies, Inc. is a privately held, clinical-stage biotechnology company headquartered in Weston, Florida, developing BPZE1 — a live attenuated intranasal vaccine candidate designed to prevent Bordetella pertussis (whooping cough) colonization and transmission — alongside its B-Tech vector platform, which the company is exploring for infectious, allergic, autoimmune and neurodegenerative disease. The BPZE1 technology originated at Institut Pasteur de Lille and is exclusively licensed to ILiAD, which announced a $115M Series B in February 2026 and received a UK MHRA Innovation Passport designation in December 2024. ILiAD publishes a static corporate and scientific website only: as of 2026-08-22 it operates no public API, developer portal, SDK, machine-readable specification, or any other programmable surface.

ILiAD Biotechnologies is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Vaccines, Life Sciences, and Pharmaceuticals.

ILiAD Biotechnologies’ developer surface includes product news and 12 more developer resources.

6.2/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-25 · rubric v0.14.0
0 APIs
CompanyBiotechnologyVaccinesLife SciencesPharmaceuticalsHealthImmunologyInfectious DiseaseClinical Trials

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-08-25 · rubric v0.14.0
Composite quality — 6.2/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.0 / 17
Access Clarity 1.8 / 17
Operational Transparency 0.0 / 11
Contract Governance 0.0 / 10
Discoverability 4.3 / 9
Regulatory Posture 1.9 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
Documented Reversibility 0 / 6
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Delegated User Identity 0 / 6
Protected Resource Metadata 0 / 5
Registration Without a Human 0 / 6
Agentic Commerce Surface 0 / 5
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/iliad-biotechnologies: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Iliad Biotechnologies Domain Security

TLSv1.2 · DMARC

SECURITY

Resources

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

Access & Security 1

Authentication, authorization, and security posture

Operate 1

Status, limits, changes, and where to get help

Commercial 1

Pricing, plans, and the legal terms of use

Company 5

The organization behind the API

Other 4

Properties that don't map to a standard resource type

Source (apis.yml)

apis.yml Raw ↑
aid: iliad-biotechnologies
name: ILiAD Biotechnologies
description: 'ILiAD Biotechnologies, Inc. is a privately held, clinical-stage biotechnology company headquartered in Weston,
  Florida, developing BPZE1 — a live attenuated intranasal vaccine candidate designed to prevent Bordetella pertussis (whooping
  cough) colonization and transmission — alongside its B-Tech vector platform, which the company is exploring for infectious,
  allergic, autoimmune and neurodegenerative disease. The BPZE1 technology originated at Institut Pasteur de Lille and is
  exclusively licensed to ILiAD, which announced a $115M Series B in February 2026 and received a UK MHRA Innovation Passport
  designation in December 2024. ILiAD publishes a static corporate and scientific website only: as of 2026-08-22 it operates
  no public API, developer portal, SDK, machine-readable specification, or any other programmable surface.'
image: https://iliadbio.com/images/logo1.png
url: https://raw.githubusercontent.com/api-evangelist/iliad-biotechnologies/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-22'
modified: '2026-08-22'
tags:
- Company
- Biotechnology
- Vaccines
- Life Sciences
- Pharmaceuticals
- Health
- Immunology
- Infectious Disease
- Clinical Trials
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://iliadbio.com/
- type: About
  url: https://iliadbio.com/company/overview.html
- type: News
  url: https://iliadbio.com/company/news.html
- type: Investors
  url: https://iliadbio.com/company/for-investors.html
- type: Careers
  url: https://iliadbio.com/careers.html
- type: ContactUs
  url: https://iliadbio.com/contact-us.html
- type: PrivacyPolicy
  url: https://iliadbio.com/privacy-policy.html
- type: DomainSecurity
  url: security/iliad-biotechnologies-domain-security.yml
- type: LLMsTxt
  url: llms/iliad-biotechnologies-llms.txt
- type: Team
  url: https://iliadbio.com/team/executive-board.html
- type: Product
  name: BPZE1 intranasal pertussis vaccine
  url: https://iliadbio.com/our_science/bpze1_vaccine.html
- type: Pipeline
  url: https://iliadbio.com/opportunity/pipeline.html
- type: Publications
  url: https://iliadbio.com/our_science/publications.html
x-enrichment:
  date: '2026-08-22'
  status: minimal
  artifacts_added: 3
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: ILiAD Biotechnologies is a clinical-stage vaccine developer whose product is BPZE1, a live attenuated intranasal
    pertussis vaccine in human trials — not software — and iliadbio.com is an 88-page static HTML site of science, patent
    PDFs and press releases where /openapi.json, /graphql, /api-docs, /llms.txt and every /.well-known/ path return a real
    404, and api./docs./developer.iliadbio.com do not resolve in DNS.
  evidence:
  - url: https://iliadbio.com/openapi.json
    status: 404
  - url: https://iliadbio.com/graphql
    status: 404
  - url: https://iliadbio.com/.well-known/agent-card.json
    status: 404
  - url: https://iliadbio.com/llms.txt
    status: 404
  - url: https://iliadbiotech.com/.well-known/security.txt
    status: 404
  checked: '2026-08-22'

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this
  • find_providersBrowse and filter every provider in the catalog.
  • get_provider_artifactsEvery artifact this provider publishes, grouped by type.
  • get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
  • get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
  • get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
  • get_provider_ratingPRO — composite, band, trend and facet scores.
  • apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
  • resolveTurn a domain, URL or GitHub org into the provider it belongs to.
  • find_cohortsEvery scored population of providers in the catalog.
All 92 tools

Call it yourself

curl for this page
This provider
curl "https://apis.io/api/v1/providers/iliad-biotechnologies"
All providers
curl "https://apis.io/api/v1/providers?limit=25"
Every operation they expose
curl "https://apis.io/api/v1/providers/iliad-biotechnologies/operations?limit=25"
How their score was established
curl "https://apis.io/api/v1/providers/iliad-biotechnologies/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no email required.

A second provider on the same verified email joins the account you already have.